Literature DB >> 7951639

Treatment of fluoxetine-induced sexual dysfunction with bupropion: a case report.

L A Labbate1, M H Pollack.   

Abstract

Antidepressant-induced sexual dysfunction is a common and significant cause of patient distress and noncompliance with treatment. A number of adjunctive pharmacologic strategies, including yohimbine, cyproheptadine, bethanechol, and amantadine, have been employed previously. We report a case of using bupropion to treat fluoxetine-induced sexual dysfunction in a 50-year-old man with a history of recurrent major depression. This is the first case of such treatment we know. Sexual dysfunction induced by fluoxetine is thought secondary to effects on the serotonin system. Bupropion is an antidepressant with minimal sexual side effects. The mechanism by which bupropion resolved this sexual dysfunction is unknown, but it may be related to its mild dopamine uptake blockade.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7951639     DOI: 10.3109/10401239409148833

Source DB:  PubMed          Journal:  Ann Clin Psychiatry        ISSN: 1040-1237            Impact factor:   1.567


  4 in total

1.  Possible Sexual Dysfunction Associated With Bupropion for Smoking Cessation: A Case Report.

Authors:  Timothy R. Berigan
Journal:  Prim Care Companion J Clin Psychiatry       Date:  1999-12

Review 2.  The Black Book of Psychotropic Dosing and Monitoring.

Authors:  Alan F Schatzberg; DeBattista Charles
Journal:  Psychopharmacol Bull       Date:  2018-01-15

3.  Switching to moclobemide to reverse fluoxetine-induced sexual dysfunction in patients with depression.

Authors:  R Ramasubbu
Journal:  J Psychiatry Neurosci       Date:  1999-01       Impact factor: 6.186

Review 4.  Psychotropic drug-induced sexual function disorders: diagnosis, incidence and management.

Authors:  D O Clayton; W W Shen
Journal:  Drug Saf       Date:  1998-10       Impact factor: 5.606

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.